No Data
Cover [Emerging Market Ratings List]
"gan ltd" <5253> Cover OVERWEIGHT new * The ratings of the above companies are as of 10/31 based on our confirmation.
San-bio and others continue to rank in, with the patent for the main development product SB623 being granted in the usa.
Sanbio <4592> is ranked (as of 1:32 p.m.). It surged temporarily. After the end of the previous trading day, they announced that a patent for their main development product SB623 (generic name: Vandetanib cell) for chronic phase cerebral infarction was granted in the USA on October 22, which seems to be attracting buyers. The stock price has been pushed down by selling pressure after a round of buying in the morning. Top volume change rate [(As of October 31, 1:32 p.m.) (Compared to the average volume of the last 5 days)] Code Stock Volume
Is it time to hold back on actively buying ahead of important events with a soft tone?
[Emerging Markets Individual Stock Strategy] Today's emerging markets are expected to see a weak development. In the U.S. stock market on the 30th, the Dow Inc fell by 91.51 points (-0.22%) to 42,141.54 points, continuing its decline. Despite the non-farm payroll statistics exceeding expectations and the third quarter domestic gross domestic product (GDP) showing strong growth, supporting the stock market expectation of a soft landing, concerns were raised due to the decline of heavy equipment manufacturer Caterpillar (CAT), the sluggish semiconductor sector, and the rise in long-term interest rates.
Cover, Truce OP, and other emerging markets press releases.
Persol Career, which handles ROXX personnel introduction services and other services, has signed dealer contracts. Miratap, code 3187, downwardly revises its forecast, with the previous term's operating profit outlook of 0.839 billion yen down from 1.3 billion yen. Ingate, which handles Cloud Works personnel introduction, recruitment support, and career counseling services, has acquired shares and become a subsidiary. Delta-P, code 4598, will exercise a large number of subscription rights in the 8th round (with revised exercise price clause), with the number of shares to be issued from the 29th to 0.3 million shares. Covering, code 5253.
Weakness, weighed down by factors such as falling US stocks [emerging markets individual stock strategy]
[Emerging markets Individual Stock Strategy] Today's emerging markets are expected to have a soft opening. On the 23rd, the US stock market saw the Dow Jones Industrial Average tumble by 409.94 points (-0.96%) to 42,514.95 points, marking a significant decline for the third consecutive day. The decline in the fast food chain McDonald's (MCD) weighed heavily, causing a decline after the opening. With the rise in long-term interest rates, high-tech stocks were also weak, leading to a significant continued decline in the market. Selling pressure dominated throughout the day, and the decline widened towards the end. Today's emerging markets are seeing a predominance of selling.
Declining due to factors such as deteriorating investor sentiment causing trading to weaken.
Last week's overview from October 14th to October 18th: Tokyo Stock Exchange Growth Index High: 642.37 Low: 621.65 Close: 623.37 Week-on-week change: -2.32% ↓ continuous decline, trading volume dwindled due to deteriorating investor sentiment. The transaction amount has fallen below 100 billion yen for 5 consecutive business days, with 83.5 billion yen on October 18th, the lowest level since May 9th. The situation continues where buying is not coming in due to deteriorating investor sentiment. Specifically, short-term funds are heading to Orth ＜260A＞, which was listed on October 11th, causing a rapid surge.